Summary:
Clinical Trials of Texas, Inc. (CTT) is conducting a research study for adults with moderate to severe plaque-type psoriasis. The study will be testing the safety and effectiveness of an investigational medication when compared to a placebo (inactive substance).
Qualified Participants Must:
• Be between 18 and 65 years of age
• Have had plaque-type psoriasis for at least 6 months
• Have psoriasis areas that cover at least 10% of your body (10 palm sizes)
• Be willing to stop using certain psoriasis medications
• Additional criteria may apply
Qualified Participants May Receive:
Study-related medical care from a board certified dermatologist, medication, testing at no cost, and compensation up to $1,250 will be available for time and travel.